Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells.
Saved in:
| Title: | Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells. |
|---|---|
| Authors: | Brownlie RJ; Leeds Institute of Medical Research at St. James's, University of Leeds, St. James's University Hospital, Leeds, United Kingdom., Carrasco Hope H; Leeds Institute of Medical Research at St. James's, University of Leeds, St. James's University Hospital, Leeds, United Kingdom.; Faculty of Science and Medicine, Université de Fribourg, Fribourg, Switzerland., Wright D; Institute of Immunology and Infection Research, University of Edinburgh, Ashworth Laboratories, Edinburgh, United Kingdom., Cook GP; Leeds Institute of Medical Research at St. James's, University of Leeds, St. James's University Hospital, Leeds, United Kingdom., Perales JC; Department of Physiological Sciences, School of Medicine, University of Barcelona, L'Hospitalet del Llobregat, Spain., Salmond RJ; Leeds Institute of Medical Research at St. James's, University of Leeds, St. James's University Hospital, Leeds, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 13; Vol. 17, pp. 1706167. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
